First National Trust Co Has $11.82 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• First National Trust Co trimmed its stake in UnitedHealth Group by 10.6% in Q3, selling 4,079 shares and ending the quarter with 34,234 shares valued at about $11.82 million.
• Several large institutions — including Norges Bank, Berkshire Hathaway, Dodge & Cox, Lone Pine and Amundi — have built multibillion-dollar positions in UNH, leaving institutional investors with roughly 87.86% ownership.
• UnitedHealth slightly beat quarterly EPS estimates ($2.11 vs. $2.09) with revenue of $113.22B (up 12.3% YoY), provided FY‑2026 guidance near $17.75 EPS, and carries a consensus analyst rating of "Moderate Buy" with a $372.13 price target.

First National Trust Co lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,234 shares of the healthcare conglomerate's stock after selling 4,079 shares during the quarter. First National Trust Co's holdings in UnitedHealth Group were worth $11,821,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in UNH. Norges Bank acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $3,837,207,000. Berkshire Hathaway Inc bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at $1,572,193,000. Dodge & Cox boosted its stake in UnitedHealth Group by 117.7% in the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate's stock valued at $2,729,912,000 after buying an additional 4,730,192 shares in the last quarter. Lone Pine Capital LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $528,273,000. Finally, Amundi lifted its stake in UnitedHealth Group by 33.8% in the 2nd quarter. Amundi now owns 6,191,871 shares of the healthcare conglomerate's stock valued at $1,904,372,000 after purchasing an additional 1,565,245 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.5%

Shares of NYSE UNH opened at $275.17 on Tuesday. The company's fifty day simple moving average is $324.91 and its 200 day simple moving average is $323.43. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36. The firm has a market cap of $249.26 billion, a PE ratio of 20.86, a P/E/G ratio of 1.27 and a beta of 0.41. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.22 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period last year, the business posted $6.81 EPS. The firm's revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on UNH shares. Sanford C. Bernstein reissued an "outperform" rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $333.00 price objective for the company. in a report on Wednesday, October 29th. KeyCorp reissued an "overweight" rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Jefferies Financial Group decreased their price target on UnitedHealth Group from $418.00 to $340.00 and set a "buy" rating for the company in a research note on Wednesday, January 28th. Finally, Evercore upgraded shares of UnitedHealth Group to a "strong-buy" rating in a report on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $372.13.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.